Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 61(21): 7719-21, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11691782

ABSTRACT

Conversion of diploidy to haploidy is a method that allows the generation of stable murine/human hybrid cell lines carrying selected human chromosomes in only a single copy. In this setting, it is possible to detect genetic mutations with greater sensitivity and reliability than in diploid cells. Using this method, we were able to identify mutations in the human mismatch repair (MMR) gene hMSH2 in hereditary nonpolyposis colon cancer families, which have escaped detection by the conventional methods. In this report, we show that such hybrid cell lines can also be a valuable tool in the study of the mutated MMR proteins, in particular the variants found in hereditary nonpolyposis colon cancer families that carry missense mutations and where it is unclear whether they predispose to colon cancer. This analysis is made possible by the fact that the human hMSH2 protein is able to complement the MMR defect in the host murine cell line.


Subject(s)
Chromosomes, Human, Pair 2/genetics , Mutation , Proto-Oncogene Proteins/genetics , Alleles , Animals , Base Pair Mismatch , Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , DNA Repair/genetics , DNA-Binding Proteins/genetics , Gene Silencing , Humans , Hybrid Cells , Mice , MutS Homolog 2 Protein , Mutation, Missense
2.
Life Sci ; 69(13): 1509-20, 2001 Aug 17.
Article in English | MEDLINE | ID: mdl-11554612

ABSTRACT

The present study describes the effect of Saquinavir on proliferation, interferon-gamma production and telomerase activity of non-stimulated, or activated non-adherent mononuclear cells (NAMNC), obtained from peripheral blood of healthy donors. Fresh NAMNC, non-stimulated or activated in vitro with PHA or with a mixture of monoclonal antibodies against CD3 and against CD28 membrane antigens (in order to obtain prevalent T cell responses), were exposed to Saquinavir before or at the time of mitogenic stimulation. Control and treated cells were tested for DNA synthesis (3H-thymidine incorporation), interferon-gamma production and telomerase activity (TRAP assay). The results indicate that Saquinavir is able to increase proliferation and interferon-gamma release in PHA-stimulated NAMNC, and telomerase activity either in non-stimulated and in PHA or antibody-activated cells. These results suggest that the activity against HIV infection afforded by Saquinavir, could be corroborated by its effects on the host. These include its adjuvant activity on mitogen-induced responses of lymphocytes, and its possible antagonistic effects against lymphoid cell senescence, through telomerase activation.


Subject(s)
HIV Protease Inhibitors/pharmacology , Neutrophils/drug effects , Saquinavir/pharmacology , Telomerase/metabolism , Antibodies, Monoclonal/pharmacology , CD28 Antigens/biosynthesis , CD3 Complex/biosynthesis , Cell Division/drug effects , DNA/biosynthesis , Humans , In Vitro Techniques , Interferon-gamma/biosynthesis , Neutrophils/enzymology , Phytohemagglutinins/pharmacology
3.
Melanoma Res ; 8(4): 323-8, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9764807

ABSTRACT

Previous studies have shown that cyclopentenone prostaglandins are endowed with antitumour activity in various murine and human tumour models. In the present investigation four human melanoma cell lines were treated with graded concentrations (4-16microg/ml) of prostaglandin A1 (PGA1) for 24 or 48 h in vitro. At the end of the treatment, cell proliferation (measured in terms of DNA synthesis) and telomerase activity were determined. The results showed that PGA1 induced concentration-dependent inhibition of DNA synthesis at 48 h but not at 24 h in SK-MEL-28 cells. In contrast, marked inhibition of telomerase activity was detected after only 24 h of PGA1 treatment. Moreover, after 48h of treatment with the agent, inhibition of telomerase was more pronounced than inhibition of cell proliferation. Additional studies performed with three freshly generated melanoma cell lines confirmed that PGA1 produced early inhibition of cell growth accompanied by marked impairment of telomerase activity. These results suggest that PGA1 could be of potential value as antitumour agent, on the basis of two distinct mechanisms: direct cytostatic/cytotoxic effects on melanoma cells, and inhibitory activity on a tumour-associated enzymatic function (i.e. telomerase) that is responsible for cancer cell immortality.


Subject(s)
Growth Inhibitors/pharmacology , Melanocytes/drug effects , Melanoma/pathology , Neoplasm Proteins/metabolism , Neoplastic Stem Cells/drug effects , Prostaglandins A/pharmacology , Skin Neoplasms/pathology , Telomerase/metabolism , Cell Division/drug effects , DNA Replication/drug effects , DNA, Neoplasm/biosynthesis , Dose-Response Relationship, Drug , Growth Inhibitors/administration & dosage , Humans , Melanocytes/enzymology , Melanocytes/pathology , Melanoma/metabolism , Neoplastic Stem Cells/enzymology , Neoplastic Stem Cells/pathology , Prostaglandins A/administration & dosage , Skin Neoplasms/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...